Arthur Sands
Chief Executive Officer presso NURIX THERAPEUTICS, INC.
Patrimonio netto: 13 M $ in data 31/03/2024
Profilo
Arthur T.
Sands is the founder of Lexicon Pharmaceuticals, Inc., which was founded in 1995.
He held the title of President, Chief Executive Officer & Director from 2011 to 2014.
Currently, Dr. Sands is the President, Chief Executive Officer & Director at Nurix Therapeutics, Inc. since 2014.
He is also a Director at Biotechnology Innovation Organization.
Previously, he was a Director at Symphony Icon, Inc. Dr. Sands received his undergraduate degree from Yale University and his graduate and doctorate degrees from Baylor College of Medicine.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
NURIX THERAPEUTICS, INC.
1.86% | 21/03/2024 | 908 333 ( 1.86% ) | 13 M $ | 31/03/2024 |
Posizioni attive di Arthur Sands
| Società | Posizione | Inizio |
|---|---|---|
| NURIX THERAPEUTICS, INC. | Chief Executive Officer | 18/09/2014 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | - |
Precedenti posizioni note di Arthur Sands
| Società | Posizione | Fine |
|---|---|---|
| LEXICON PHARMACEUTICALS, INC. | Founder | 07/07/2014 |
Symphony Icon, Inc.
 Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Director/Board Member | - |
Formazione di Arthur Sands
| Yale University | Undergraduate Degree |
| Baylor College of Medicine | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| LEXICON PHARMACEUTICALS, INC. | Health Technology |
| NURIX THERAPEUTICS, INC. | Health Technology |
| Aziende private | 2 |
|---|---|
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Symphony Icon, Inc.
Symphony Icon, Inc. Pharmaceuticals: MajorHealth Technology Symphony Icon, Inc. engages in the manufacture of pharmaceutical products. The company was founded in June 2007 and is headquartered in Rockville, MD. | Health Technology |
- Borsa valori
- Insiders
- Arthur Sands
